Saturday, November 11, 2006 6:30 AM to 8:30 AM

September 26, 2006

A CME Breakfast Symposium

Saturday, November 11, 2006
6:30 AM to 8:30 AM

The Venetian Resort Hotel and Casino
3355 Las Vegas Blvd S
Las Vegas, Nevada

REGISTER ON LINE
OR CALL TOLL FREE
888-248-0036

Program Chair and Moderator

Robert Noecker, MD, MBAVice Chair
Director of Glaucoma Service

UPMC Eye Center
Associate Professor of Ophthalmology
University of Pittsburgh
Pittsburgh, Pennsylvania


Faculty

Jason Bacharach, MD
Associate Clinical Professor in Ophthalmology
California Pacific Medical Center – San Francisco
Medical Director
North Bay Eye Associates, Inc
Petaluma, California

Monte S. Dirks, MD
Clinical Assistant Professor, Ophthalmology
Department of Surgery
Sanford School of Medicine
University of South Dakota
Black Hills Regional Eye Institute
Rapid City, South Dakota

Andrew G. Iwach, MDAssociate Clinical Professor
University of California, San Francisco
Executive Director
Glaucoma Center of San Francisco
San Francisco, California


Target Audience
This educational activity is intended for comprehensive ophthalmologists.

Statment Of Need And Activity Description
Successful long-term management of glaucoma is a process of continual evaluation of disease progression and treatment with medical therapy and, more recently, interventional approaches of laser and surgical therapies. As physicians are offered new technologies and pharmaceutical agents, they need to understand how disease management approaches may change during the pursuit of the goal to improve individual patient care. This symposium will provide attendees new information for making use of the full spectrum of glaucoma management tools.

Learning Objectives
Upon completion of this activity, participants should be able to:
• Discuss the importance of early detection of glaucoma
• Evaluate the current technologies for glaucoma diagnosis and its long-term management
• Formulate treatment algorithms with pharmacologic agents alone, as well as in combination with laser treatment
• Discuss the appropriate use of laser and surgical options
• Use medical and/or laser therapies for long-term glaucoma management

AGENDA
6:30 AM – 7:00 AM - Attendee Registration

7:00 AM – 7:05 AM - Welcome and Introduction

7:05 AM – 7:20 AM - Predicting the Future-The Role of Optic Nerve Imaging in OHTS
Robert Noecker, MD, MBA

7:20 AM – 7:35 AM - Evaluating Success and Adherence With Medical, Laser, and Surgical Therapy
Monte S. Dirks, MD

7:35 AM – 7:40 AM - Panel Discussion

7:40 AM – 7:55 AM - Pearls to Successful Laser Trabeculoplasty
Jason Bacharach, MD

7:55 AM – 8:00 AM - Panel Discussion

8:00 AM – 8:15 AM - Following the Optimal Treatment Algorithm for Glaucoma Management
Andrew G. Iwach, MD

8:15 AM – 8:20 AM - Panel Discussion

8:20 AM – 8:30 AM - Q&A Session

Accreditation Statement
This continuing medical education activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The New York Eye and Ear Infirmary and cme2, an independent subsidiary of Advanstar Communications Inc, publisher of Ophthalmology Times. The New York Eye and Ear Infirmary is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The New York Eye and Ear Infirmary designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement

The New York Eye and Ear Infirmary requires that each participant/teacher in a CME-accredited educational activity disclose the existence of any financial interest and/or other relationship(s) (eg, paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation. Speakers are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity. The disclosed information in no way presumes to assess the participant's qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or perceived, which is related to a specific event. Full disclosure of faculty and commercial relationships, if any, will be made at the program.

Provider Disclosure
The New York Eye and Ear Infirmary received a financial benefit from ISTA Pharmaceuticals, Lumenis, and Heidelberg Engineering to administer this educational activity.

PRE-REGISTER ON LINE
or call 888-248-0036
or 218-740-7130

Related Content:

News